VLO has recovered to $387.72 after last week's dip to $377, a 2.8% weekly gain that keeps the stock above the consensus mean price target and leaves the Goldman-versus-Jefferies debate squarely unresolved heading into October earnings.
Options positioning remains the clearest expression of market uncertainty. Put demand has been elevated for weeks and hasn't meaningfully retreated with the price recovery. The put/call ratio closed at 1.43, above its 20-day average of 1.31, and the trend in the underlying history tells the fuller story: the PCR was below 1.10 throughout August and climbed steadily through September, peaking near 1.50 mid-week before pulling back slightly. That month-long drift toward downside protection, running alongside a 10% monthly price gain, suggests investors are hedging a position they still want to own rather than outright exiting. The 52-week PCR high is 1.78, so the current reading is elevated but not extreme.
The lending market sends a much calmer signal than options. Short interest has been quietly falling, dropping 6.6% over the week to 3.1% of the free float, and is now below the 10-million-share level it held through most of September. Borrowing costs have compressed in parallel, down roughly 20% over both the past week and past month to 0.36%, firmly in the low-cost-to-borrow category. Availability is exceptionally loose at over 4,000%, meaning there are approximately 40 shares available to borrow for every one already borrowed. Shorts are not being squeezed out, they are simply choosing to reduce exposure into the rally.
The Street debate is sharpening as the October 22 earnings date approaches. Goldman's Neil Mehta raised his target to $457 a week ago, keeping his Buy and pushing roughly 18% above the current price. Raymond James and UBS both have $450 targets. Yet Jefferies downgraded to Hold on September 22 with a $401 target, and the consensus mean sits at $360, now below where the stock is trading. That inversion, where the average target trails the price, reflects the pace of VLO's run rather than bearish conviction: Morgan Stanley's raise to $411 from $255 in mid-September was a large move, but the Equal-Weight rating signals the firm sees fair value close to current levels. The bull case rests on Gulf Coast refining complexity and Diamond Green Diesel optionality. The bear case is that a stock up more than 130% year-to-date on diesel margin tailwinds is vulnerable to any softening in crack spreads or RIN credit prices. At a PE of 9.6 and EV/EBITDA of 6.2, valuation is not stretched in absolute terms, but the EV/EBITDA multiple has compressed by 1.7 points over the past 30 days as the EV base has grown faster than near-term earnings estimates have moved.
The ORTEX short score has been drifting lower all week, from 37.2 on September 17 to 35.2 on September 29, moving in the opposite direction from the share price. A falling short score alongside rising price and falling short interest suggests the bearish data inputs into that score are gradually unwinding rather than building. Retail attention has also picked up, with the Wikipedia-based attention signal running at 1.8 standard deviations above its own 90-day history as of September 22, a level consistent with the name drawing more eyes after a sustained momentum run.
Among peers, MPC gained 0.6% on the week while PSX and DINO both fell around 1%. PBF was the outperformer with a 5.3% weekly gain, though from a much lower base. VLO's 2.8% weekly move lands it in the middle of the refining pack, a notable contrast to its year-to-date leadership position, hinting that some of the relative outperformance gap may be narrowing at the margin.
The Q3 print on October 22 is the next hard test: the question is whether Gulf Coast crack spreads and Diamond Green Diesel volumes in the quarter support the thesis that the year's rally has fundamental backing, or whether the market decides the Jefferies downgrade was the more prescient read.
See the live data behind this article on ORTEX.
Open VLO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
